Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARK EVERETT ROLFS

Allopathic & Osteopathic Physicians Family Medicine

NPI
1861781544
CMS profile
1099788
Location
INDIANAPOLIS, IN

General Payments · PY2018–2024

$749.29

  • Reported across 37 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$355.98

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $355.98 15

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $34.75 2
PY2019 $39.97 3
PY2020 $11.47 1
PY2021 $17.12 1
PY2022 $79.44 4
PY2023 $210.56 11
PY2024 $355.98 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $32.09 08/15/2024 Food and Beverage Undisputed 01/23/2026 1105968866 CMS
Bioventus LLC $27.17 07/03/2024 Food and Beverage Undisputed 01/23/2026 1137448375 CMS
Dexcom, Inc. $20.68 01/08/2024 Food and Beverage Undisputed 01/23/2026 1153319952 CMS
Insulet Corporation $17.09 04/10/2024 Food and Beverage Undisputed 01/23/2026 1116802948 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.84 04/03/2024 Food and Beverage Undisputed 01/23/2026 1143309002 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.66 06/12/2024 Food and Beverage Undisputed 01/23/2026 1143309005 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.74 07/30/2024 Food and Beverage Undisputed 01/23/2026 1143309009 CMS
Janssen Pharmaceuticals, Inc $25.07 06/12/2024 Food and Beverage Undisputed 01/23/2026 1078017940 CMS
Lilly USA, LLC $24.63 05/11/2024 Food and Beverage Undisputed 01/23/2026 1135178195 CMS
Neurocrine Biosciences, Inc. $32.01 04/23/2024 Food and Beverage Undisputed 01/23/2026 1150822769 CMS
Neurocrine Biosciences, Inc. $27.09 05/28/2024 Food and Beverage Undisputed 01/23/2026 1150833492 CMS
Novo Nordisk Inc $23.60 09/10/2024 Food and Beverage Undisputed 01/23/2026 1097310978 CMS
Otsuka America Pharmaceutical, Inc. $15.97 01/10/2024 Food and Beverage Undisputed 01/23/2026 1118971216 CMS
Xeris Pharmaceuticals, Inc. $17.16 01/15/2024 Food and Beverage Undisputed 01/23/2026 1144604644 CMS
Xeris Pharmaceuticals, Inc. $22.18 07/15/2024 Food and Beverage Undisputed 01/23/2026 1144604646 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.